Latest
-
Can Amgen Turn Around?
Markets Newsletter editor George Putnam thinks the struggling biotech giant will rebound. He's worth a listen.
Markets -
Amgen: Biotech Value
Markets Shares of this biotechnology giant have suffered -- yet the company's pipeline and growth strategy look as healthy as ever.
Markets -
Amgen: Biotech Promise
Markets Shares of the world's largest biotech company should perform well in 2006, says one analyst.
Markets